Prosecution Insights
Last updated: October 02, 2026
Application No. 18/441,208

METHODS FOR REAL TIME TRACKING OF A CATHETER SPLINE

Non-Final OA §112
Filed
Feb 14, 2024
Examiner
TURCHEN, ROCHELLE DEANNA
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Biosense Webster (Israel) Ltd.
OA Round
3 (Non-Final)
58%
Grant Probability
Moderate
3-4
OA Rounds
1y 5m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
388 granted / 675 resolved
-12.5% vs TC avg
Strong +29% interview lift
Without
With
+29.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
19 currently pending
Career history
698
Total Applications
across all art units

Statute-Specific Performance

§101
6.4%
-33.6% vs TC avg
§103
50.1%
+10.1% vs TC avg
§102
15.1%
-24.9% vs TC avg
§112
23.3%
-16.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 675 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after allowance or after an Office action under Ex Parte Quayle, 25 USPQ 74, 453 O.G. 213 (Comm'r Pat. 1935). Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, prosecution in this application has been reopened pursuant to 37 CFR 1.114. Applicant's submission filed on 28 April 2026 has been entered. Examiner Note Examiner notes claims 9-18, set forth in the claim set filed 30 December 2025, are renumbered as claims 8-17 as set forth in the Notice of Allowance dated 5 March 2026. Further, renumbered claim 15 (previously claim 16) was verified as depending from renumbered claim 14 (previously claim 15) during an interview with Applicant on 17 March 2026. Claim Objections Claims 1-6, 16 and 17 are objected to because of the following informalities: “the spline” in line 22 of claim 1 should state “the flexible spline”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-17 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the shape" in line 1. There is insufficient antecedent basis for this limitation in the claim. Claim 1 states “a shape of the flexible spline” in line 9. It is unclear as to whether the claim is attempting to refer back to “the shape of a flexible spline” as set forth in the preamble or if the claim is attempting to define an additional shape. Claim 1 recites the limitation “the first and second endpoints locations” in lines 11 and 13-14. There is insufficient antecedent basis for this limitation in the claim. Claim 1 recites the limitation "the length of a chord" in line 13. There is insufficient antecedent basis for this limitation in the claim. Claim 1 recites the limitation “the length of a control polyline” in line 14. There is insufficient antecedent basis for this limitation in the claim. Claim 1 recites the limitation “the quadrative Bezier curve parameters” in line 20. There is insufficient antecedent basis for this limitation in the claim. Claim 1 recites the limitation “the physical flexible spline” in lines 21-22. Claim 1 recites the limitation “the first endpoint location” in line 35. There is insufficient antecedent basis for this limitation in the claim. Claim 1 recites the limitation “the second endpoint location” in line 36. There is insufficient antecedent basis for this limitation in the claim. Claim 7 states “a distal end of the distal end assembly” in line 7. It is unclear as to whether this limitation is attempting to refer back to “a distal end” as defined in line 5. Claim 7 recites the limitation "the flexible spline" in line 14. There is insufficient antecedent basis for this limitation in the claim. Examiner notes “a plurality of splines” is set forth in line 4 of the claim. Claim 7 recites the limitation "the first and second endpoints locations" in lines 15-16. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the length of a chord" in lines 17-18. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the length of a control polyline" in 18-19. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the first endpoint location" in line 19. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the second endpoint location" in line 20. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the quadratic Bezier curve parameters" in line 24. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the physical flexible spline" in line 25. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "the spline" in line 26. There is insufficient antecedent basis for this limitation in the claim. Claim 7 states “determined in step b)” in line 30; however, there are no steps listed in the claim. Claim 7 recites the limitation "the known catheter spline length" in line 33. There is insufficient antecedent basis for this limitation in the claim. Claim 7 states “on a display” in line 39. It is unclear as to whether the limitation is attempting to further define “an electronic display” a set forth in line 38. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROCHELLE DEANNA TURCHEN whose telephone number is (571)270-7104. The examiner can normally be reached Mon - Fri 6:30-2:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christopher Koharski can be reached at (571)272-7230. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROCHELLE D TURCHEN/ Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Show 3 earlier events
Oct 01, 2025
Final Rejection mailed — §112
Dec 30, 2025
Request for Continued Examination
Jan 28, 2026
Response after Non-Final Action
Mar 17, 2026
Examiner Interview (Telephonic)
Mar 17, 2026
Examiner Interview Summary
Apr 28, 2026
Request for Continued Examination
May 01, 2026
Response after Non-Final Action
Jun 08, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745990
ULTRASOUND DIAGNOSTIC APPARATUS AND OPERATION METHOD OF ULTRASOUND DIAGNOSTIC APPARATUS
2y 5m to grant Granted Sep 29, 2026
Patent 12746080
Extending Reach Inside The MRI-Bore: A 7-DOF Low-Friction, Hydrostatic Teleoperator
2y 2m to grant Granted Sep 29, 2026
Patent 12745920
CONNECTED IMPLANT WITH REFLECTOR
1y 11m to grant Granted Sep 29, 2026
Patent 12733980
SYSTEM AND METHOD FOR ABLATION TREATMENT OF TISSUE WITH INTERACTIVE GUIDANCE
3y 3m to grant Granted Sep 15, 2026
Patent 12733903
ULTRASOUND PROBE HANGER AND METHOD FOR SUSPENDING A WIRELESS ULTRASOUND TRANSDUCER WITHIN A CHAMBER OF AN ULTRASOUND TRANSDUCER HIGH-LEVEL DISINFECTION (HLD) SYSTEM
2y 7m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
58%
Grant Probability
86%
With Interview (+29.0%)
4y 0m (~1y 5m remaining)
Median Time to Grant
High
PTA Risk
Based on 675 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month